1-112667121-T-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006135.3(CAPZA1):c.633T>A(p.Asp211Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000128 in 1,610,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006135.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAPZA1 | NM_006135.3 | c.633T>A | p.Asp211Glu | missense_variant | 8/10 | ENST00000263168.4 | NP_006126.1 | |
CAPZA1 | XM_017002424.3 | c.633T>A | p.Asp211Glu | missense_variant | 8/10 | XP_016857913.1 | ||
CAPZA1 | XM_011542225.4 | c.*65T>A | 3_prime_UTR_variant | 9/9 | XP_011540527.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPZA1 | ENST00000263168.4 | c.633T>A | p.Asp211Glu | missense_variant | 8/10 | 1 | NM_006135.3 | ENSP00000263168.3 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152252Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000132 AC: 33AN: 250398Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135446
GnomAD4 exome AF: 0.000133 AC: 194AN: 1458524Hom.: 0 Cov.: 28 AF XY: 0.000130 AC XY: 94AN XY: 725820
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152370Hom.: 0 Cov.: 32 AF XY: 0.0000268 AC XY: 2AN XY: 74518
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 26, 2023 | The c.633T>A (p.D211E) alteration is located in exon 8 (coding exon 8) of the CAPZA1 gene. This alteration results from a T to A substitution at nucleotide position 633, causing the aspartic acid (D) at amino acid position 211 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at